In the present study, we characterized the expression of HDAC6 in several human glioblastoma cohorts and glioma stem cell subpopulation, and tested the effect of a recently described HDAC6-specific inhibitor20 in GBM. This evidence concerns the gene HDAC6 and glioblastoma.